Heeger C, Vogler J, Eitel C, Feher M, Popescu S, Kirstein B
Eur Heart J Digit Health. 2024; 5(3):356-362.
PMID: 38774365
PMC: 11104456.
DOI: 10.1093/ehjdh/ztae013.
Xiong S, Qin S, Tong L, Long Y, Luo Y, Feng Q
Front Cardiovasc Med. 2024; 11:1364940.
PMID: 38586175
PMC: 10995217.
DOI: 10.3389/fcvm.2024.1364940.
Zhao J, Xie Y, Meng Z, Liu C, Wu Y, Zhao F
Emerg Crit Care Med. 2024; 3(3):104-114.
PMID: 38314258
PMC: 10836842.
DOI: 10.1097/ec9.0000000000000095.
Hu C
Nat Prod Bioprospect. 2024; 14(1):12.
PMID: 38282092
PMC: 10822835.
DOI: 10.1007/s13659-024-00432-4.
Ascandar N, Chervu N, Bakhtiyar S, Cho N, Kim S, Orellana M
PLoS One. 2023; 18(9):e0291774.
PMID: 37729193
PMC: 10511080.
DOI: 10.1371/journal.pone.0291774.
Hydrogen Sulfide: Physiological Roles and Therapeutic Implications against COVID-19.
Abolfazli S, Ebrahimi N, Morabi E, Asgari Yazdi M, Zengin G, Sathyapalan T
Curr Med Chem. 2023; 31(21):3132-3148.
PMID: 37138436
DOI: 10.2174/0929867330666230502111227.
Approach to Protecting Patients and Staff in Nuclear Cardiology Laboratories in Response to the COVID-19 Pandemic.
Van Tosh A, Nichols K
Ann Nucl Cardiol. 2023; 6(1):11-14.
PMID: 37123493
PMC: 10133924.
DOI: 10.17996/anc.20-00133.
COVID-19 HEART unveiling as atrial fibrillation: pathophysiology, management and future directions for research.
Kanuri S, Sirrkay P, Ulucay A
Egypt Heart J. 2023; 75(1):36.
PMID: 37120772
PMC: 10149046.
DOI: 10.1186/s43044-023-00359-0.
Effect of COVID-19 on cardiac electrophysiology practice: a systematic review of literature.
Almas T, Ehtesham M, Khan A, Ramtohul R, Nazir M, Zaidi S
Ann Med Surg (Lond). 2023; 85(4):884-891.
PMID: 37113877
PMC: 10129206.
DOI: 10.1097/MS9.0000000000000328.
Overview of the cardio-metabolic impact of the COVID-19 pandemic.
Barkhordarian M, Behbood A, Ranjbar M, Rahimian Z, Prasad A
Endocrine. 2023; 80(3):477-490.
PMID: 37103684
PMC: 10133915.
DOI: 10.1007/s12020-023-03337-3.
Clinicians' Experiences of Implementing a Telerehabilitation Toolkit During the COVID-19 Pandemic: Qualitative Descriptive Study.
Munce S, Andreoli A, Bayley M, Guo M, Inness E, Kua A
JMIR Rehabil Assist Technol. 2023; 10:e44591.
PMID: 36897634
PMC: 10039414.
DOI: 10.2196/44591.
Real-World Disparities in Remote Follow-Up of Cardiac Implantable Electronic Devices and Impact of the COVID-19 Pandemic: A Single-Center Experience.
Lehmann H, Sharma K, Bhatia R, Mills T, Lang J, Li G
J Am Heart Assoc. 2023; 12(3):e027500.
PMID: 36688364
PMC: 9973665.
DOI: 10.1161/JAHA.122.027500.
Sudden Occurrence of Pacemaker Capture Failure during Irreversible Electroporation Ablation for Prostate Cancer in Post-COVID-19 Patient: A Case Report.
Chae M, Lee N, Koh H
Medicina (Kaunas). 2022; 58(10).
PMID: 36295568
PMC: 9607448.
DOI: 10.3390/medicina58101407.
Effects of COVID-19 on Arrhythmia.
Zhan Y, Yue H, Liang W, Wu Z
J Cardiovasc Dev Dis. 2022; 9(9).
PMID: 36135437
PMC: 9504579.
DOI: 10.3390/jcdd9090292.
Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19.
deAndres-Galiana E, Fernandez-Martinez J, Alvarez-Machancoses O, Bea G, Galmarini C, Kloczkowski A
Comput Biol Med. 2022; 149:106029.
PMID: 36067633
PMC: 9423878.
DOI: 10.1016/j.compbiomed.2022.106029.
Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients.
Maloberti A, Giannattasio C, Rebora P, Occhino G, Ughi N, Biolcati M
Biomedicines. 2022; 10(8).
PMID: 36009487
PMC: 9406191.
DOI: 10.3390/biomedicines10081940.
Realtime Remote Programming in Patients Carrying Cardiac Implantable Electronic Devices Requiring Emergent Reprogramming.
Xiong S, Li J, Tong L, Hou J, Yang S, Qi L
Front Cardiovasc Med. 2022; 9:871425.
PMID: 35651905
PMC: 9149410.
DOI: 10.3389/fcvm.2022.871425.
Cloud Follow-Up in Patients With Cardiovascular Implantable Electronic Devices: A Single-Region Study in China.
Tong L, Xiong S, Hou J, Li J, Qin S, Zhang Y
Front Cardiovasc Med. 2022; 9:864398.
PMID: 35615564
PMC: 9124837.
DOI: 10.3389/fcvm.2022.864398.
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence.
LHuillier A, Pagano S, Baggio S, Meyer B, Andrey D, Nehme M
Eur J Clin Invest. 2022; 52(10):e13818.
PMID: 35598178
PMC: 9348059.
DOI: 10.1111/eci.13818.
Perspectives of the community in the developing countries toward telemedicine and pharmaceutical care during the COVID-19 pandemic.
Alsayed A, Halloush S, Hasoun L, Alnatour D, Al-Dulaimi A, Alnajjar M
Pharm Pract (Granada). 2022; 20(1):2618.
PMID: 35497904
PMC: 9014891.
DOI: 10.18549/PharmPract.2022.1.2618.